Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study

Li Xiaoxin; Chen Youxin; Zhang Junjun; Xu Xun; Zhang Feng; Cheung Chui Ming Gemmy; Yu Rui; Kazmi Husain; Sowade Olaf; Zeitz Oliver

首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study

【24h】

Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study

机译：玻璃体内AfliBercept与中国新生血管年龄相关黄斑变性的患者的光动力学治疗：视觉研究的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: SIGHT compared intravitreal aflibercept injections (IAI) with photodynamic therapy (PDT) in Chinese patients with predominantly classic choroidal neovascularization (CNV) secondary to neovascular age-related macular degeneration (nAMD).

机译：目的：视觉与术治疗玻璃体内AfliBercept（IAI）与光学疗法（PDT）与主要经典脉络膜新生血管（CNV）中的术治疗中的术治疗（PDT）与中血管结合的新血管结合（CNV）进行了相互关联的黄斑变性（NAMD）。

著录项

来源
《Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics》 |2017年第6期|共10页
作者
Li Xiaoxin; Chen Youxin; Zhang Junjun; Xu Xun; Zhang Feng; Cheung Chui Ming Gemmy; Yu Rui; Kazmi Husain; Sowade Olaf; Zeitz Oliver;
展开▼
作者单位

Peking Univ Peoples Hosp Peoples Eye Ctr Dept Ophthalmol 11 Xizhimen South St Beijing 100044;

Peking Union Med Colleague Hosp Dept Ophthalmol Beijing Peoples R China;

Sichuan Univ West China Hosp West China Sch Med Dept Ophthalmol Chengdu Peoples R China;

Shanghai Gen Hosp Dept Ophthalmol Shanghai Peoples R China;

CMU Beijing Tongren Hosp Dept Ophthalmol Beijing Peoples R China;

Singapore Eye Res Inst Dept Ophthalmol Singapore Singapore;

Bayer US Dept Ophthalmol Whippany NY USA;

Regeneron Pharmaceut Inc Ophthalmol Tarrytown NY 10591 USA;

Bayer AG Dev Pharmaceut Berlin Germany;

Bayer AG Dev Pharmaceut Berlin Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
intravitreal aflibercept; SIGHT; neovascular age-related macular degeneration; photodynamic therapy;

机译：玻璃体内术般的;视觉;新生血管年龄相关的黄斑变性;光动力疗法;

相似文献

外文文献
中文文献
专利

1. Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study [J] . Li Xiaoxin, Chen Youxin, Zhang Junjun, Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics . 2017,第6期

机译：玻璃体内AfliBercept与中国新生血管年龄相关黄斑变性的患者的光动力学治疗：视觉研究的结果
2. Two years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study dataTwo years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study data [J] . Kanda Koji, Sato Tomohito, Taguchi Manzo, Investigative ophthalmology & visual science . 2017,第8期

机译：根据固定的2个月间隔接受AfliBercept的眼睛两年的结果与新生血管年龄相关的黄斑变性：观察研究DataTwo岁月后的眼睛，接受AfliBercept的目的，根据固定的2个月的新生血管年龄相关性黄斑变性：观察研究数据
3. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. [J] . Weigert G, Michels S, Sacu S, British journal of ophthalmology . 2008,第3期

机译：玻璃体内贝伐单抗（Avastin）与光动力疗法联合玻璃体内曲安西龙治疗与年龄相关的新血管性黄斑变性：前瞻性，随机对照临床研究的6个月结果。
4. Assessment of Choroidal Neovascular Membranes Secondary to Age-Related Macular Degeneration Using Feature Selection [C] . E. Brankin, P.J. McCullagh, W.P. Patton European Conference of the International Federation for Medical and Biological Engineering . 2013

机译：用特征选择评估二次与年龄相关黄斑变性的脉络膜新生血管膜
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study [O] . Xiaoxin Li, Youxin Chen, Junjun Zhang, -1

机译：玻璃体腔内阿柏西普与光动力疗法在中国新血管性年龄相关性黄斑变性患者中的应用：SIGHT研究结果
7. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study [O] . Weigert, G, Michels, S, Sacu, S, 2008

机译：玻璃体内贝伐单抗（Avastin）与光动力疗法联合玻璃体内曲安西龙治疗与年龄相关的新生血管性黄斑变性：前瞻性，随机对照临床研究的6个月结果

Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study

摘要

著录项

相似文献

相关主题

期刊订阅